Evidence map›Paper›PMID 37097512›Full record

ArticleJournal of molecular neuroscience : MN2023

Attenuation of Age-Related Hearing Impairment in Senescence-Accelerated Mouse Prone 8 (SAMP8) Mice Treated with Fatty Acid Synthase Inhibitor CMS121.

Tammy B Pham, Ely Cheikh Boussaty, Antonio Currais, Pamela Maher, David R Schubert, Uri Manor, Rick A Friedman

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular neuroscience : MN, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Ferroptosis and hearing loss: from molecular mechanisms to therapeutic interventions.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Tammy B PhamDepartment of Otolaryngology-Head and Neck Surgery, University of California San Diego Health, 92037, La Jolla, CA, USA.
Ely Cheikh BoussatyDepartment of Otolaryngology-Head and Neck Surgery, University of California San Diego Health, 92037, La Jolla, CA, USA.
Antonio CurraisCellular Neurobiology Laboratory, Salk Institute for Biological Studies, 92037, La Jolla, CA, USA.
Pamela MaherCellular Neurobiology Laboratory, Salk Institute for Biological Studies, 92037, La Jolla, CA, USA.
David R SchubertCellular Neurobiology Laboratory, Salk Institute for Biological Studies, 92037, La Jolla, CA, USA.
Uri ManorWaitt Advanced Biophotonics Center, Salk Institute for Biological Studies, 92037, La Jolla, CA, USA.
Rick A FriedmanDepartment of Otolaryngology-Head and Neck Surgery, University of California San Diego Health, 92037, La Jolla, CA, USA. rafriedman@health.ucsd.edu.
Salk Institute for Biological Studies · USUniversity of California, San Diego · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Reuben Shaw · 1985 to 2026
$82.8M
Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's DiseaseR01AG067331 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI PETRASCHECK, MICHAEL · 2020 to 2024
$4.9M
The Contribution of Kidney Disease to Age-Associated Cognitive DeclineRF1AG061296 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MAHER, PAMELA ANNE · 2019 to 2019
$3.2M
Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of ADR44AI104034 · NIAID · VIROGENICS, INC. · PI RASCHKE, WILLIAM C · 2018 to 2020
$2.9M
The genetic basis for age-related hearing loss in outbred miceR01DC018566 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FRIEDMAN, RICK A · 2020 to 2024
$2.7M
Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of ADR42AI104034 · NIAID · VIROGENICS, INC. · PI MAHER, PAMELA ANNE · 2016 to 2017
$1.5M
Modulation of the Innate Immune System by Fisetin for the Treatment of ADR41AI104034 · NIAID · VIROGENICS, INC. · PI MAHER, PAMELA ANNE · 2013 to 2014
$600k
A Novel Model System for Restoring Hearing in vivoR21DC018237 · NIDCD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI COLEMAN, TODD P, KYRIAKAKIS, PHILLIP · 2020 to 2021
$505k
NCI NIH HHS CA014195NCI NIH HHS P30 CA014195NIAID NIH HHS R41 AI104034NIAID NIH HHS R42 AI104034NIAID NIH HHS R44 AI104034NIA NIH HHS R01 AG067331NIA NIH HHS RF1 AG061296NIDCD NIH HHS R01 DC018566NIDCD NIH HHS R21 DC018237NIH HHS AI104034NIH HHS R01AG067331NIH HHS R01DC018566
6 · The paper itself

Abstract

In the senescence-accelerated mouse prone 8 (SAMP8) mouse model, oxidative stress leads to premature senescence and age-related hearing impairment (ARHI). CMS121 inhibits oxytosis/ferroptosis by targeting fatty acid synthase. The aim of our study was to determine whether CMS121 is protective against ARHI in SAMP8 mice. Auditory brainstem responses (ABRs) were used to assess baseline hearing in sixteen 4-week-old female SAMP8 mice, which were divided into two cohorts. The control group was fed a vehicle diet, while the experimental group was fed a diet containing CMS121. ABRs were measured until 13 weeks of age. Cochlear immunohistochemistry was performed to analyze the number of paired ribbon-receptor synapses per inner hair cell (IHC). Descriptive statistics are provided with mean ± SEM. Two-sample t-tests were performed to compare hearing thresholds and paired synapse count across the two groups, with alpha = 0.05. Baseline hearing thresholds in the control group were statistically similar to those of the CMS121 group. At 13 weeks of age, the control group had significantly worse hearing thresholds at 12 kHz (56.5 vs. 39.8, p = 0.044) and 16 kHz (64.8 vs. 43.8, p = 0.040) compared to the CMS121 group. Immunohistochemistry showed a significantly lower synapse count per IHC in the control group (15.7) compared to the CMS121 group (18.4), p = 0.014. Our study shows a significant reduction in ABR threshold shifts and increased preservation of IHC ribbon synapses in the mid-range frequencies among mice treated with CMS121 compared to untreated mice.

Indexed as

CochleaPresbycusisAnimalsFatty Acid SynthasesFemaleHair Cells, Auditory, InnerMiceOxidative StressSynapsesFatty Acid SynthasesABRAge-related hearing impairmentCMS121Hearing lossSAMP8

Identifiers

PMID37097512
PMCPMC10200781
OpenAlexW4366988409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.